|Bid||1.44 x 0|
|Ask||1.46 x 0|
|Day's Range||1.38 - 1.47|
|52 Week Range||0.84 - 2.00|
|PE Ratio (TTM)||84.71|
|Earnings Date||Apr 30, 2018 - May 4, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.44|
ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that the Government of Uruguay through its regulatory authority IRCCA (Cannabis Regulation and Control Institute) has granted the Company an additional land package of approximately 55,000 square foot in order to increase its production capacity. “A relevant milestone that demonstrates the confidence that the Government has placed in our Company to continue executing the terms of our recreational cannabis license granted for 5 years on January 14, 2016,” commented Alejandro Antalich, Chief Executive Officer of ICC Labs.
Grit Updates the Market on Recent Corporate Initiatives & Milestones. TORONTO, June 22, 2018-- GRIT CAPITAL INC. a capital markets advisory firm known for its aggressive“ out of the box” thinking to capture ...
ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that it has completed its first outdoor harvest of hemp. The Company harvested hemp planted on approximately 430 acres of land distributed between its Canelones and Flores sites. The Company is now commencing the drying process for the harvested material, which will take between three to four weeks, and is preparing the soil for the next seeding, expected to occur next September.
ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that KSK Labs, a 100% subsidiary of Global Group Kalapa, of which ICC Labs recently acquired 25%, subject to TSX Venture Exchange approval, has closed a presale agreement with a Spain-based company, VenPharma, in order to distribute cannabidiol (“CBD”) products in Spanish pharmacies and drugstores. The agreed first order is of 140,000 CBD products between sublingual CBD oils of 2% and 10%, CBD creams and infusions based on hemp, to be distributed through 500 point of sales. The intention with the next orders is to sell over than 370,000 CBD products annually through all the 1,300 points of sales.
Undervalued companies, such as Big 8 Split and ICC Labs, trade at a price less than their true values. Smart investors can make money from this discrepancy by buying theseRead More...
ICC Labs enters into its first CBD/THC presale agreement in Colombia. Colombia is the third country in the Latin American market where ICC Labs has now taken steps to commence sales, after México and Brazil, opening up large potential markets with a total population of approximately 380 million people. VANCOUVER, British Columbia, June 05, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce it has entered into a presale agreement with a Colombia based company, Hlessing Industries (“Hlessing”) to supply cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) derivatives for medicinal purposes in Colombia.
ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce it has filed its interim financial results for the first quarter ended March 31, 2018. The financial statements and management discussion and analysis for the three months ended March 31, 2018, are available on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on ICC Labs' website at www.icclabs.com. During the first quarter of 2018, the Company continued to take steps to expand its footprint in the Latin American market, and to gain access to the European and Canadian markets.
ICC Labs Inc. (“ICC Labs” or the “Company”) (ICC.V) (2Q9.F) is pleased to announce that it has signed a letter of intent with CanPharma GmbH (“CanPharma”), a licensed importer and wholesaler of narcotics in the Federal Republic of Germany. Through its relationship with CanPharma, ICC Labs intends to export to Germany cannabidiol (CBD) isolate, oils and other derivatives, as well as various medicinal tetrahydrocannabinol (THC) cannabis products, including dried flowers and cannabis extracts from our facilities in Uruguay and Colombia. The export arrangement for (THC) cannabis products is subject to receipt of the requisite regulatory approvals and the negotiation of definitive agreements by the end of second quarter in 2018.
VANCOUVER , March 28, 2018 /CNW/ - Trading resumes in: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Resumption (ET): 1:30 PM IIROC can make a decision to impose a temporary suspension (halt) of trading ...
VANCOUVER , March 28, 2018 /CNW/ - The following issues have been halted by IIROC: Company: ICC LABS INC. TSX-Venture Symbol: ICC Reason: Pending Company Contact Halt Time (ET): 9:18 AM IIROC can make ...
Highlights: Upon approval, the new 1 million square foot greenhouse will be located on government owned land in Uruguay. THC plants will be produced exclusively for medicinal...
- Positions CDB Small Cap with Unrivaled Share Structure and Cash to Accelerate Global Agreements and ...
VANCOUVER , Jan. 25, 2018 /CNW/ - Trading resumes in: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Resumption (ET): 10:11:35.591 AM IIROC can make a decision to impose a temporary suspension (halt) of ...
VANCOUVER , Jan. 25, 2018 /CNW/ - The following issues have been halted by IIROC: Company: ICC Labs Inc. TSX-Venture Symbol: ICC Reason: Single Stock Circuit Breaker Halt Time (ET): 10:06:35.591 AM IIROC ...
Highlights: The Ministry of Justice and Law of the Republic of Colombia granted ICC Labs Inc., through its subsidiary ICC International Cannabis Corp Colombia S.A.S., a license for the cultivation of non-psychoactive......